Epidermal CYP2 family cytochromes P450

Toxicology and Applied Pharmacology

Volumn 195, Issue 3, 2004, Pages 278-287

  Du, Liping ^a   Hoffman, Susan M G ^b   Keeney, Diane S ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MIAMI UNIVERSITY   (United States)

^c VA Tennessee Valley Hlthcare System   (United States)

Author keywords

CYP; Cytochromes P450; Epidermis; Keratinocyte; Skin

Indexed keywords

ARACHIDONIC ACID; BETA NAPHTHOFLAVONE; CYTOCHROME P450; CYTOCHROME P450 2; CYTOCHROME P450 2A6; CYTOCHROME P450 2A7; CYTOCHROME P450 2B6; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2; CYTOCHROME P450 2R1; CYTOCHROME P450 2S1; CYTOCHROME P450 2U1; CYTOCHROME P450 2W1; DEXAMETHASONE; ESTRADIOL; ESTRONE; LINOLEIC ACID; MELATONIN; PROGESTERONE; RETINOIC ACID; RETINOL; SALICYLIC ACID; TESTOSTERONE; TRYPTAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D;

CELL CULTURE; CELL DIFFERENTIATION; DRUG EFFECT; EPIDERMIS; GENE EXPRESSION; GENE FUNCTION; HUMAN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MOLECULAR BIOLOGY; MULTIGENE FAMILY; NONHUMAN; REVIEW; SKIN APPENDAGE; SKIN EPITHELIUM; TRANSCRIPTION REGULATION;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; SKIN; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 1542616893     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.09.020     Document Type: Review

References (58)

1. Ahmad N., Agarwal R., Mukhtar H. Cytochrome P-450-dependent drug metabolism in skin. Clin. Dermatol. 14:1996;407-415.
2. Baron J., Kawabata T.T., Redick J.A., Knapp S.A., Wick D.G., Wallace R.B., Jakoby W.B., Guengerich F.P. Localization of carcinogen-metabolizing enzymes in human and animal tissues. Rydström J., Montelius J., Bengtsson M. Extrahepatic Drug Metabolism and Chemical Carcinogenesis. 1983;73-88 Elsevier, Amsterdam.
3. Baron J.M., Höller D., Schiffer R., Frankenberg S., Neis M., Merk H.F., Jugert F.K. Expression of multiple cytochromes P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J. Invest. Dermatol. 116:2001;541-548.
4. Bickers D.R. Xenobiotic metabolism in skin. Goldsmith L.A. Physiology, Biochemistry, and Molecular Biology of the Skin. 2nd ed. 1991;1480-1501 Oxford Univ. Press, New York.
5. Bickers D.R., Dutta-Choudhury T., Mukhtar H. Epidermis: a site of drug metabolism in neonatal rat skin. Mol. Pharmacol. 21:1982;239-247.
6. Bikle D.D., Pillai S. Vitamin D, calcium, and epidermal differentiation. Endocr. Rev. 14:1993;3-19.
7. Botto F., Seree E., Khyari S.E., De Sousa G., Massacrier A., Placidi M., Cau P., Pellet W., Rahmani R., Barra Y. Tissue-specific expression and methylation of the human CYP2E1 gene. Biochem. Pharmacol. 48:1994;1095-1103.
8. Chen N., Whitehead S.E., Caillat A.W., Gavit K., Isphording D.R., Kovacevic D., McCreary M.B., Hoffman S.M.G. Identification and cross-species comparisons of CYP2F subfamily genes in mammals. Mutat. Res. 499:2002;155-161.
9. Cheng J.B., Motola D.L., Mangelsdorf D.J., Russell D.W. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J. Biol. Chem. 278:2003;38084-38093.
10. Conney A.H. Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450. Annu. Rev. Pharmacol. Toxicol. 43:2003;1-30.
11. Czerwinski M., McLemore T.L., Gelboin H.V., Gonzalez F.J. Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res. 54:1994;1085-1091.
12. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54:1992;63-128.
13. Ding X., Kaminsky L.S. Human hepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43:2003;149-173.
14. Ding S., Lake B.G., Friedberg T., Wolf C.R. Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochem. J. 306:1995;161-166.
15. Ekins S., Wrighton S.A. The role of CYP2B6 in human xenobiotic metabolism. Drug Metab. Rev. 31:1999;719-754.
16. Finta C., Zaphiropoulos P.G. The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. Genomics. 63:2000;433-438.
17. Friedberg T., Grassow M.A., Bartlomowicz-Oesch B., Siegert P., Arand M., Adesnik M., Oesch F. Sequence of a novel cytochrome CYP2B cDNA coding for a protein which is expressed in a sebaceous gland, but not in the liver. Biochem. J. 287:1992;775-783.
18. Gonzalez M.-C., Marteau C., Franchi J., Migliore-Samour D. Cytochrome P450 4A11 in human keratinocytes: effects of ultraviolet irradiation. Br. J. Dermatol. 145:2001;749-757.
19. Helvig C., Chuang S., Taimi M., Jones G., Petkovich M., White J.A., Korczak B. CYP2U1, a thymus and cerebellum expressed cytochrome P450 converts arachidonic acid into bioactive derivatives 19- and 20-HETE. 13th International Conference on Cytochromes P450, Prague:2003;. (Abstract).
20. Hoffman S.M.G., Nelson D.R., Keeney D.S. Organization, structure, and evolution of the CYP2 gene cluster on human chromosome 19. Pharmacogenetics. 11:2001;687-698.
21. Hotchkiss S.A.M. Skin as a xenobiotic metabolizing organ. Prog. Drug Metab. 13:1992;217-262.
22. Janmohamed A., Dolphin C.T., Phillips I.R., Shephard E.A. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem. Pharmacol. 62:2001;777-786.
23. Jugert F.K., Agarwal R., Kuhn A., Bickers D.R., Merk H.F., Mukhtar H. Multiple cytochromes P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone. J. Invest. Dermatol. 102:1994;970-975.
24. Kao J., Carver M.P. Skin metabolism. Marzulli F.N., Maibach H.I. Dermatotoxicology. 4th ed. 1991;143-200 Hemisphere Publishing Corp. New York.
25. Karlgren M., Ingelman-Sundberg M. A novel thymus-specific cytochrome P450, CYP2U1. 13th International Conference on Cytochromes P450, Prague:2003;. (Abstract).
26. Keeney D.S., Skinner C., Travers J.B., Capdevila J.H., Nanney L.B., King L.E. Jr., Waterman M.R. Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate oxygenase activity. J. Biol. Chem. 273:1998;32071-32079.
27. Keeney D.S., Skinner C., Wei S., Friedberg T., Waterman M.R. A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid. J. Biol. Chem. 273:1998;9279-9284.
28. Klose T.S., Blaisdell J.A., Goldstein J.A. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J. Biochem. Mol. Toxicol. 13:1999;289-295.
29. Ladd P.A., Du L., Capdevila J.H., Mernaugh R., Keeney D.S. Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes. J. Biol. Chem. 278:2003;35184-35192.
30. Merk H.F., Jugert F.K., Frankenberg S. Biotransformations in the skin. Marzulli F.N., Maibach H.I. Dermatotoxicology. 5th ed. 1996;61-73 Hemisphere Publishing Corp. New York.
31. Miles J.S., Spurr N.K., Gough A.C., Jowett T., McLaren A.W., Brook J.D., Wolf C.R. A novel human cytochrome P450 gene (P450IIB): chromosomal localization and evidence for alternative splicing. Nucleic Acids Res. 16:1988;5783-5795.
32. Mukhtar H. Cutaneous cytochrome P-450. Mukhtar H. Pharmacology of the Skin. 1992;139-147 CRC Press, Boca Raton.
33. Nebert D.W., Russell D.W. Clinical importance of the cytochromes P450. Lancet. 360:2002;1155-1162.
34. Nebert D.W., Nelson D.R., Coon M.J., Estabrook R.W., Feyereisen R., Fujii-Kuriyama Y., Gonzalez F.J., Guengerich F.P., Gunsalus I.C., Johnson E.F., Loper J.C., Sato R., Waterman M.R., Waxman D.J. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol. 10:1991;1-14.
35. Nelson D.R. Cytochrome P450 Homepage [web site]. http://drnelson.utmem. edu/cytochromeP450.html:2003.
36. Nelson D.R., Zeldin D., Hoffman S.M.G., Maltais L., Wain H., Nebert D.W. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, and nomenclature recommendations for genes, pseudogenes, and alternative splice variants. Pharmacogenetics. 2004;. (in press).
37. Pham M.-A., Magdalou J., Totis M., Fournel-Gigleux S., Siest G., Hammock B.D. Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyl transferases in rat skin. Biochem. Pharmacol. 38:1989;2187-2194.
38. Ramachandran S., Lear J.T., Ramsay H., Smith A.G., Bowers B., Hutchinson P.E., Jones P.W., Fryer A.A., Strange R.C. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype. Cancer Epidemiol., Biomarkers Prev. 8:1999;61-67.
39. Reiners J.J. Jr., Cantu A.R., Pavone A. Distribution of constitutive and polycyclic aromatic hydrocarbon-induced cytochrome P-450 activities in murine epidermal cells that differ in their stages of differentiation. Butterworth B.E., Slaga T.J., Farland W., McClain M. Chemically Induced Cell Proliferation Implications for Risk Assessment. 1991;123-135 Wiley, New York.
40. Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab. Rev. 34(1 and 2):2002;83-448.
41. Richter-Hintz D., Their R., Steinwachs S., Kronenberg S., Fritsche E., Sachs B., Wulferink M., Tonn T., Esser C. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. J. Invest. Dermatol. 120:2003;765-770.
42. Rivera S.P., Saarikoski S.T., Hankinson O. Identification of a novel dioxin-inducible cytochrome P450. Mol. Pharmacol. 61:2002;255-259.
43. Rylander T., Neve E.P.A., Ingelman-Sundberg M., Oscarson M. Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem. Biophys. Res. Commun. 281:2001;529-535.
44. Saeki M., Saito Y., Nagano M., Teshimia R., Ozawa S., Sawada J. mRNA expression of multiple cytochromes P450 isozymes in four types of cultured skin cells. Int. Arch. Allergy Immunol. 127:2002;333-336.
45. Sampol E., Mirrione A., Villard P.H., Piccerelle P., Scoma H., Berbis P., Barra Y., Durand A., Lacarelle B. Evidence for a tissue-specific induction of cutaneous CYP2E1 by dexamethasone. Biochem. Biophys. Res. Commun. 235:1997;557-561.
46. Sando G.N., Howard E.J., Madison K.C. Induction of ceramide glucosyltransferase activity in cultured human keratinocytes. J. Biol. Chem. 271:1996;22044-22051.
47. Scarborough P.E., Ma J., Qu W., Zeldin D.C. P450 subfamily CYP2J and their role in bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab. Rev. 31:1999;205-234.
48. Sheng J., Guo J., Hua Z., Caggana M., Ding X. Characterization of human CYP2G genes: widespread loss-of-function mutations and genetic polymorphism. Pharmacogenetics. 10:2000;667-678.
49. Smith G., Wolf C.R., Deeni Y.Y., Dawe R.S., Evans A.T., Comrie M.M., Ferguson J., Ibbotson S.H. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet. 361:2003;1336-1343.
50. Tsao C.-C., Coulter S.J., Chen A., Luo G., Clayton N.P., Maronpot R., Goldstein J.A., Zeldin D.C. Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products. J. Pharmacol. Exp. Ther. 299:2001;39-47.
51. Wang H., Lanza D.L., Yost G.S. Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. Arch. Biochem. Biophys. 349:1998;329-340.
52. Wang H., Donley K.M., Keeney D.S., Hoffman S.M.G. Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and a comparison to the syntenic human cluster. Environ. Health Perspect. Toxicogenomics. 111:2003;1835-1842.
53. Warner S.C., Finta C., Zaphiropoulos P.G. Intergenic transcripts containing a novel human cytochrome P450 2C exon 1 spliced to sequences from the CYP2C9 gene. Mol. Biol. Evol. 18:2001;1841-1848.
54. Xie Q., Zhang Q.-Y., Zhang Y., Su T., Gu J., Kaminsky L.S., Ding X. Induction of mouse CYP2J by pyrazole in the eye, kidney, liver, lung, olfactory mucosa, and small intestine, but not in the heart. Drug Metab. Dispos. 28:2000;1311-1316.
55. Yamano S., Nhamburo P.T., Aoyama T., Meyer U.A., Inaba T., Kalow W., Gelboin H.V., McBride O.W., Gonzalez F.J. cDNA cloning and sequence and cDNA-directed expression of human P450 IIBI: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry. 28:1989;7340-7348.
56. Yengi L.G., Xiang Q., Pan J., Scatina J., Kao J., Ball S.E., Fruncillo R., Ferron G., Wolf C.R. Quantitation of cytochrome P450 mRNA levels in human skin. Anal. Biochem. 316:2003;103-110.
57. Zaphiropoulos P.G. RNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liver. Nucleic Acids Res. 27:1999;2585-2590.
58. Zhu Z., Hotchkiss S.A., Boobis A.R., Edwards R.J. Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. Biochem. Biophys. Res. Commun. 297:2002;65-70.